As the U.S. tightens its stance on bilateral trade, imposing higher tariffs on Indian pharmaceutical products could be counterproductive, warns Kiran Mazumdar-Shaw, Chairperson, Biocon Group. Speaking at the Asia Economic Dialogue 2025, she emphasized the risks of disrupting global healthcare supply chains. “A global reset is clearly visible in the form of decoupling and rising … Continue reading Reappraising India’s Role in Global Healthcare